A novel fusion gene and a common α(0)-thalassemia deletion cause hemoglobin H disease in a Chinese family

Blood Cells Mol Dis. 2013 Jun;51(1):31-4. doi: 10.1016/j.bcmd.2013.01.013. Epub 2013 Mar 6.

Abstract

Genetic recombination has been implicated as a mechanism that drives mutagenesis in the human globin gene clusters, either as a result of unequal crossover or gene conversion. In this paper, a novel fusion gene was identified in a Chinese girl with hemoglobin H disease. The proband's father was a compound heterozygote for the common -α(4.2) deletion and this fusion gene, and her mother was heterozygous for the common --(SEA) deletion (--(SEA)/αα). Both her parents had a hypochromic and microcytic red cell phenotype and a normal hemoglobin level. Molecular studies revealed a compound heterozygote for the --(SEA) deletion and this novel fusion gene and the patient had the clinical features of classic hemoglobin H disease. Sequence analysis revealed that the mutant gene was the result of a fusion between the α2 and ψα1 genes. The recombination began at exon 3 of α2 gene, crossing with exon 3 of the ψα1 gene. With this recombination, the conservative 3'UTR of the α2 gene was changed, and an extensive transcript with a new signal 1048bp 3' to the terminating codon was found. The abnormal transcripts of the fusion gene read through the intergenic sequence.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Base Sequence
  • Child, Preschool
  • Female
  • Gene Deletion*
  • Gene Fusion*
  • Hemoglobin H / genetics*
  • Heterozygote
  • Humans
  • Pedigree
  • Transcription, Genetic
  • alpha-Globins / genetics*
  • alpha-Thalassemia / diagnosis
  • alpha-Thalassemia / genetics*

Substances

  • alpha-Globins
  • Hemoglobin H